A Theory and Evidence-Based Artificial Intelligence-Driven Motivational Digital Assistant to Decrease Vaccine Hesitancy: Intervention Development and Validation

Author:

Li Yan1ORCID,Lee Kit-Ching1,Bressington Daniel2,Liao Qiuyan3,He Mengting1,Law Ka-Kit1,Leung Angela Y. M.14ORCID,Molassiotis Alex5,Li Mengqi1ORCID

Affiliation:

1. School of Nursing, The Hong Kong Polytechnic University, Hong Kong 999077, China

2. Faculty of Health, Charles Darwin University, Darwin 0815, Australia

3. School of Public Health, The University of Hong Kong, Hong Kong 999077, China

4. Research Institute for Smart Aging (RISA), The Hong Kong Polytechnic University, Hong Kong 999077, China

5. College of Arts, Humanities and Education, University of Derby, Derby DE22 1GB, UK

Abstract

Vaccine hesitancy is one of the top ten threats to global health. Artificial intelligence-driven chatbots and motivational interviewing skills show promise in addressing vaccine hesitancy. This study aimed to develop and validate an artificial intelligence-driven motivational digital assistant in decreasing COVID-19 vaccine hesitancy among Hong Kong adults. The intervention development and validation were guided by the Medical Research Council’s framework with four major steps: logic model development based on theory and qualitative interviews (n = 15), digital assistant development, expert evaluation (n = 5), and a pilot test (n = 12). The Vaccine Hesitancy Matrix model and qualitative findings guided the development of the intervention logic model and content with five web-based modules. An artificial intelligence-driven chatbot tailored to each module was embedded in the website to motivate vaccination intention using motivational interviewing skills. The content validity index from expert evaluation was 0.85. The pilot test showed significant improvements in vaccine-related health literacy (p = 0.021) and vaccine confidence (p = 0.027). This digital assistant is effective in improving COVID-19 vaccine literacy and confidence through valid educational content and motivational conversations. The intervention is ready for testing in a randomized controlled trial and has high potential to be a useful toolkit for addressing ambivalence and facilitating informed decision making regarding vaccination.

Funder

Health and Medical Research Fund - Commissioned Research on the Novel Coronavirus Disease (COVID-19), Food and Health Bureau, The Government of the Hong Kong Special Administrative Region

Publisher

MDPI AG

Reference48 articles.

1. World Health Organization (2024, February 16). Vaccines and Immunization. Available online: https://www.who.int/health-topics/vaccines-and-immunization#tab=tab_1.

2. Estimating the lifetime cost of vaccination in 23 European Countries: A modeling study;Bencina;Expert Rev. Vaccines,2023

3. World Health Organization (2024, February 16). Immunization Agenda 2030: A Global Strategy to Leave No One Behind. Available online: https://www.who.int/teams/immunization-vaccines-and-biologicals/strategies/ia2030.

4. Vaccine hesitancy: Definition, scope and determinants;MacDonald;Vaccine,2015

5. Vaccine hesitancy: A contemporary issue for new COVID-19 vaccination;Sookaromdee;Int. J. Prev. Med.,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3